Clinical Trials Browser

INDUSTRY × Waldenstrom Macroglobulinemia × ofatumumab × Clear all

NCT00811733 2017-05-30

A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia

Phase 2 Completed

37 enrolled 25 charts

Waldenstrom Macroglobulinemia